The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Study among fisherfolk, sex workers, truck drivers and others at higher risk of HIV finds many are willing to try PrEP – but only for around six weeks.
We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.
The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.
The proportion of South Africans ever testing for HIV increased from 30% to 75% between 2005 and 2017 – but differences remain in who is getting tested
HIV drug resistance among treatment-naïve people in China rising rapidly from 2012 and tops 10% in Central China.
We have launched a new mobile app made in collaboration with community health workers in Southern Africa. Find out all you need to know about Boost!
Mobile testing and door-to-door approaches result in a 25% increase in status awareness, with particularly significant gains in diagnosing HIV-positive young people and men.
An evaluation of Zvandiri, a teen-led programme for HIV-positive adolescents in Zimbabwe, finds it significantly improves treatment outcomes and boosts self-esteem.
UK efforts to end the HIV epidemic by 2030 are advancing, but challenges remain around reaching those undiagnosed and those diagnosed late.
The first global and regional estimates showing the link between herpes and HIV finds 30% of new HIV infections in 2016 were attributable to the STI.
